Abstract
Cardiovascular disease remains the most common cause of death in chronic kidney disease, including peritoneal dialysis (PD) patients, and has an incidence that is many times that of the general population.1 In an effort to understand why cardiovascular disease is so common in this population, risk factors known to be associated with atherosclerosis in the general population have also been studied in chronic kidney disease. Dyslipidemia is one such risk factor. This paper reviews the possible etiology of dyslipidemia in PD, its clinical relevance, and current treatment recommendations.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
